Category: Mindray Medical International Ltd.
Chinese medical device maker Mindray Medical pays $15 million to settle a "commercial dispute" with Beckman Coulter.
China-based Mindray Medical lowered its full-year financial outlook on sluggish hospital purchases at home, even as sales and profits each gain 15% during the company's 3rd quarter.
Medical device companies including Cardinal Health and Mindray Medical are among the firms awarded contracts and extensions worth nearly $196 million by the U.S. Defense Dept.
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.
CAZ Investments raises a $29 million round to back commercialized medical firms.
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.
Mindray Medical agrees to spend $105 million to acquire ultrasound device maker Zonare Medical Systems.
Mindray (NYSE:MR) said it's agreed to a $105 million buyout of Zonare Medical Systems and its ultrasound technology.
Two heads are better than 1 at Mindray Medical, which appointed chief strategic officer Cheng Minghe as co-CEO alongside chief Li Xiting.
Mindray Medical (NYSE:MR) chief Li Xiting will share the corner office, so to speak, with new co-CEO Cheng Minghe, who takes the new title in addition to continuing as the company's chief strategic officer.
Cheng is one of the founders of the Shenzhen, China-based company, and has worked in various roles since 1991.
Mindray Medical misses 1st-quarter revenue numbers, sending shares down 6.8% on Wall Street before recovering to pre-earnings levels